title: Is single-agent chemotherapy acceptable in platinum-sensitive relapsed ovarian cancer?
authors.forename: Rony M
authors.initials: RM
authors.lastname: Abou-Jawde
authors.forename: Satinderjit S
authors.initials: SS
authors.lastname: Oberoi
mesh_terms: D000970:Antineoplastic Agents / Q000627:therapeutic use*; D017326:Clinical Trials, Phase III as Topic; D005260:Female; D006801:Humans; D009364:Neoplasm Recurrence, Local / Q000188:drug therapy* / Q000401:mortality; D009944:Organoplatinum Compounds / Q000627:therapeutic use*; D010051:Ovarian Neoplasms / Q000188:drug therapy* / Q000401:mortality; D015996:Survival Rate
chemical_list: D000970:Antineoplastic Agents; D009944:Organoplatinum Compounds